ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,842Medicare Part D Prescriptions Filled, Including Refills

Rank: 720 out of 2170

$345K Total Retail Price of All Prescriptions

Rank: 833 out of 2170

319 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
36% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Carolina
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 319 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

9% of this provider’s 319 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 5,643 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
SIMVASTATIN 492 426 1 1
LEVOTHYROXINE SODIUM 329 280 2 5
AMLODIPINE BESYLATE 283 259 3 4
OMEPRAZOLE 219 170 4 2
METFORMIN HCL 204 175 5 8
LISINOPRIL 192 143 6 3
ATORVASTATIN CALCIUM 186 179 7 12
ALENDRONATE SODIUM 171 148 8 36
LISINOPRIL-HYDROCHLOROTHIAZIDE 167 146 9 20
PRAVASTATIN SODIUM 125 97 10 11
FUROSEMIDE 124 108 11 6
CRESTOR 116 79 12 24
HYDROCODONE-ACETAMINOPHEN 111 96 S3 13 7
WARFARIN SODIUM 109 87 14 15
CARVEDILOL 109 98 14 26
METOPROLOL SUCCINATE 108 90 16 13
CITALOPRAM HBR 101 95 17 19
HYDROCHLOROTHIAZIDE 100 92 18 9
SYNTHROID 98 98 19 27
SERTRALINE HCL 90 61 20 25
ZOLPIDEM TARTRATE 85 54 21 17
MELOXICAM 84 83 22 28
AMLODIPINE BESYLATE-BENAZEPRIL 81 80 23 67
TRAMADOL HCL 76 59 24 18
LOSARTAN POTASSIUM 75 44 25 21
LOSARTAN-HYDROCHLOROTHIAZIDE 71 67 26 42
FENOFIBRATE 69 53 27 57
BENAZEPRIL HCL 64 63 28 55
ADVAIR DISKUS 62 51 29 45
PANTOPRAZOLE SODIUM 60 56 30 39
GLIMEPIRIDE 59 59 31 31
METOPROLOL TARTRATE 59 48 31 10
PREDNISONE 58 46 33 41
POTASSIUM CHLORIDE 54 41 34 16
EVISTA 54 54 34 147
NAMENDA 53 53 36 48
PROAIR HFA 50 35 37 43
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 21, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.